MEDS Cash Flow Statement


* In Millions (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
2009 (Q3)
09-30
2009 (Q2)
06-30
2009 (Q1)
03-31
2008 (Q4)
12-31
2008 (Q3)
09-30
2008 (Q2)
06-30
2008 (Q1)
03-31
2007 (Q4)
12-31
2007 (Q3)
09-30
2007 (Q2)
06-30
2007 (Q1)
03-31
2006 (Q4)
12-31
2006 (Q3)
09-30
Report Filing: 2024-04-22 2024-01-16 2023-08-18 2023-05-15 2023-03-27 2022-11-07
1234
Net Income/Starting Line -11715965 648250 -1974878 -677953 -1303029 -528742
1234
Cash From Operating Activities -867524 -603112 328566 -931531 1230050 -576925
1234
Depreciation and Amortization 715450 228540 53521 52319 21793 64557
1234
Deferred Income Tax -1037204 -610074 -23596 -77920 0 0
1234
Stock Based Compensation 178473 3760 15813 63486 412521 29216
1234
Other Non-Cash Items 5245591 -526425 23596 14213 1736740 51571
1234
Changes in Working Capital 4708927 -953477 2226327 -320110 832978 -193527
1234
Accounts Receivable -81492 -173531 -91522 52761 269184 168762
1234
Inventory 4271960 2664 -35005 -6672 -43632 926510
1234
Accounts Payable 753454 673245 347813 -166887 -15259 -450780
1234
Deferred Revenue -234995 -1455855 2005041 -199312 622685 -838019
1234
Other Working Capital 0 0 0 0 0 0
1234
Cash From Investing Activities -350000 -207111 -51803 333197 -114943 -55730
1234
Investments in Property Plant and Equipment 138875 0 -51803 -87072 -114943 -55730
1234
Payments for Acquisitions -350000 5546 0 0 0 0
1234
Purchases of Securities 0 0 0 0 0 0
1234
Proceeds from Sales and Maturities of Securities 0 0 0 0 0 0
1234
Other Investing Activities -552066 -212657 -51803 420269 -114943 -55730
1234
Cash From Financing Activities 1335398 114958 -725281 681257 -303189 -7857
1234
Debt Repayment -25000 -225000 0 0 0 0
1234
Common Stock Issued 516399 0 1615 7 209801 0
1234
Common Stock Repurchased -25000 0 0 0 0 0
1234
Dividends Paid 0 0 0 0 0 0
1234
Other Financing Activities 1310398 339958 -726896 681250 -512990 -7857
1234
Effect of Forex Changes on Cash 3 -16265 0 0 0 0
1234
Net Change in Cash 117877 -711530 -448518 82923 811918 -640512
1234
Cash at Beginning of Period 34031 745561 1194079 1111156 321715 962227
1234
Cash at End of Period 151908 34031 745561 1194079 1133633 321715
1234
Free Cash Flow -728649 -603112 276763 -1018603 1115107 -632655
1234
Operating Cash Flow -867524 -603112 328566 -931531 1230050 -576925
1234
Capital Expenditure 138875 0 -51803 -87072 -114943 -55730
1234

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.